Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index; 7 of the 73 sources its claims cite were checked for support.
Abstract
BACKGROUND: Invasive candidiasis and candidemia are frequently encountered in the nosocomial setting, particularly in the intensive care unit (ICU). OBJECTIVES AND METHODS: To review the current management of invasive candidiasis and candidemia in non-neutropenic adult ICU patients based on a review of the literature and a European expert panel discussion. RESULTS AND CONCLUSIONS: Candida albicans remains the most frequently isolated fungal species followed by C. glabrata. The diagnosis of invasive candidiasis involves both clinical and laboratory parameters, but neither of these are specific. One of the main features in diagnosis is the evaluation of risk factor for infection which will identify patients in need of pre-emptive or empiric treatment. Clinical scores were built from those risk factors. Among laboratory diagnosis, a positive blood culture from a normally sterile site provides positive evidence. Surrogate markers have also been proposed like 1,3 beta-D: glucan level, mannans, or PCR testing. Invasive candidiasis and candidemia is a growing concern in the ICU, apart from cases with positive blood cultures or fluid/tissue biopsy, diagnosis is neither sensitive nor specific. The diagnosis remains difficult and is usually based on the evaluation of risk factors.
Overview
CoChat Summary
TL;DR
This narrative review summarizes the epidemiology and diagnosis of invasive candidiasis and candidemia in adult non-neutropenic ICU patients, emphasizing high attributable mortality and persistent diagnostic difficulty. It reports that Candida spp. are common ICU bloodstream pathogens, C. albicans remains predominant although non-albicans species are increasingly reported, and diagnosis relies on risk factors, colonization indices, cultures, and non-culture markers with imperfect accuracy.
Key findings
- Candida spp. account for 6–11% of positive nosocomial bloodstream infections; in a US surveillance study, 4.6 bloodstream infections per 10,000 admissions and 9% of all bloodstream infections. ICU candidemia was 10.1% of bloodstream infections versus 7.9% on general wards, and one study reported 15.8/10,000 patient-days in ICUs versus 0.15/10,000 on medical wards and 0.69/10,000 on surgical wards.
- Attributable mortality of candidiasis was estimated at 49% in 108 matched pairs, with crude mortality 61% in case patients versus 12% in controls; a systematic review of seven matched cohort and case-control studies reported attributable mortality ranging from 5 to 71%. Invasive candidiasis and candidemia were associated with increased ICU and hospital stay of 12.7 and 15.5 days, respectively.
- C. albicans remained the main pathogen overall, but non-albicans species were increasingly reported. In an Italian ICU study of 182 candidemia episodes, 40% were C. albicans, 23% C. parapsilosis, 15% C. glabrata, 9% C. tropicalis, and 13% other species; in a Canadian 1-day point-prevalence study of 409 isolates, C. albicans accounted for 72% and C. glabrata 16%, with only 4% resistant to fluconazole and/or itraconazole.
- Diagnosis is challenging: clinical manifestations are non-specific, blood cultures are often positive late, and about 50% of blood culture samples may be inadequate (<20 mL). Reported test performance included beta-D-glucan sensitivity 69.9% and specificity 87.1%; combined mannan/antimannan sensitivity 80% and specificity 93%; and a PCR assay sensitivity 90.9% and specificity 100%. The Pittet colonization index threshold of 0.5 and a corrected index were associated with 100% sensitivity and specificity in a 29-patient study; the Leon Candida score cut-off of 2.5 had sensitivity 81% and specificity 74%.
Methods
- Narrative review of the international literature on management of invasive candidiasis and candidemia in adult non-neutropenic ICU patients, focused here on epidemiology and diagnosis.
- No primary patient cohort, systematic search strategy, or meta-analysis is described; the paper synthesizes findings from cited epidemiologic, risk-factor, prediction-rule, colonization-index, and laboratory-diagnostic studies.
- Main analysis is descriptive, covering incidence and mortality, Candida species distribution, risk factors, clinical prediction rules, colonization indices, and laboratory markers including beta-D-glucan, mannan/antimannan, germ tube antibody, and PCR.
Limitations
- The paper states that diagnosis is neither sensitive nor specific apart from positive blood cultures or fluid/tissue biopsy, and that there is a clear need for more specific diagnostic markers. It also states that uncertainty exists around the relative mortality of different Candida species, requiring well-controlled studies, and that the influence of azole prophylaxis on Candida epidemiology has not been clearly elucidated.
- The paper notes limitations of specific cited evidence, including that one prediction study involved only 19 patients with candidemia, that the Pittet colonization-index study evaluated 29 patients, that PCR results need further evaluation, and that beta-D-glucan requires validation in the appropriate ICU setting before routine use.
- Evident from the text: as a narrative review without a described systematic search or formal quality assessment, the reported incidence, species distribution, and mortality estimates vary widely across heterogeneous, often small, retrospective, or single-center studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 0 Not valid · 56 Not checked · 9 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“A larger study conducted over a 5-year period in Italy recorded 182 episodes of ICU candidemia, with an average incidence of 2.22 episodes/10,000 patient-days/ year [22].”
What the sources say
- Supportedcites [22] Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C (2006) Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6:21 source
The Abstract Methods (p. 1) and Background/Methods sections establish a five-year (1999–2003) retrospective study in the ICU of San Martino University Hospital, Genoa, Italy. The Results (p. 1) and Table 2 state 182 episodes of candidaemia with an average incidence of 2.22 episodes/10 000 patient-days/year (range 1.25–3.06), matching every element of the claim. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The results of this study reflected a shift toward an increased rate of infection with non-albicans Candida species.”
What the sources say
- Supportedcites [22] Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C (2006) Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6:21 source
The Background identifies the study as a retrospective analysis of bloodstream infections in an ICU in Genova, Italy. The Results report that the proportion of non-albicans isolates increased during 1999–2003, and the Discussion explicitly describes a shift toward non-albicans Candida species in the ICU population. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The authors developed a corrected index (product of the CI times the ratio of the number of dbs showing heavy growth to the total of dbs growing Candida spp.) which was associated with a 100% sensitivity and specificity.”
What the sources say
- Supportedcites [46] Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751-758 source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“and candidemia occurred more frequently in non-neutropenic patients than in patients with neutropenia [1,7].”
What the sources say
- Not checked yetcites [1] Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309-317 source
- Not checked yetcites [7] Bougnoux ME, Kac G, Aegerter P, d'Enfert C, Fagon JY (2008) Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 34:292-299 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Comparing fluconazole-susceptible with resistant strains in 161 patients, Kovacicova et al. [19] found a significantly higher attributable mortality in patients infected with a fluconazole-resistant strain.”
What the sources say
- Not checked yetcites [19] Kovacicova G, Krupova Y, Lovaszova M, Roidova A, Trupl J, Liskova A, Hanzen J, Milosovic P, Lamosova M, Macekova L, Szovenyiova Z, Purgelova A, Obertik T, Bille J, Krcmery V (2000) Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia? J Infect Chemother 6:216- 221 source
plainstates an associationn = 161- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
15 more claims
Create a free account to see all 71 claims and to verify the 66 references still open.
- It may state two separate claims as one. 41
- Probably not a substantial claim. 18
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These possible treatment delays likely occurred because of the non-specific clinical presentation of candidemia, low sensitivity of blood cultures for candidemia detection, and the time needed to detect Candida in blood cultures [15, 27].”
From Treatment practices for adults with candidemia at 9 active surveillance sites—United States, 2017–2018. (2021) · cites this paper as [27]
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 4×
“varies depending on the population surveyed [1, 2].”
BackgroundInfluentialEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 4×
“varies depending on the population surveyed [1, 2].”
BackgroundInfluentialMorrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286 · cited 1×
“specimens require invasive procedures [29, 30, 46].”
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140 · cited 1×
“Attributable mortality of candidiasis was evaluated retrospectively between 1997 and 2001 in 108 matched pairs [12], the crude mortality among case patients was 61% compared with 12% in”
ResultHospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798 · cited 2×
“specimens require invasive procedures [29, 30, 46].”
BackgroundOstrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432470 · Cited by 669 · cited 1×
“1%, respectively [47], as there are a high number of false positive results.”
BackgroundBlumberg, H. M., Jarvis, W. R., Soucie, J. M., Edwards, J. E., Patterson, J. E., Pfaller, M. A., Rangel‐Frausto, M. S., Rinaldi, M. G., Saiman, L., Wiblin, R. T., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/321811 · Cited by 661 · cited 3×
“Table 1 Commonly recognized risk factors for invasive Candida infection [2, 34, 35]”
BackgroundLeón, C., Ruiz-Santana, S., Saavedra, P., Almirante, B., Nolla-Salas, J., Álvarez-Lerma, F., Garnacho-Montero, J., & León, M. Á. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202208.37364.7d · Cited by 659 · cited 3×
“[28] described a clinical score based on four parameters derived from a logit model: surgery, multifocal colonization, total parenteral nutrition, and severe sepsis.”
BackgroundMethodViscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601 · cited 1×
“[18] also suggested that C.”
Cited by
Items 101–176 of 176
Chandenier, J., & Désoubeaux, G. (2014) · Bulletin de la Société de pathologie exotique · doi:10.1007/s13149-014-0376-3 · Cited by 11
“Les antibiothérapies à large spectre, cathéters veineux, épurations extra-rénales, chirurgies du tube digestif, ou chimiothérapies sont les principaux facteurs de risques de ces candidoses profondes (12).”
BackgroundRecurrent candidaemia and pacemaker wire infection with Candida albicans
Glöckner, A. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02139.x · Cited by 9
Chronic Lyme Disease Complex and Its Commonly Undiagnosed Primary and Secondary Co-Infections
Smith, A., Oertle, J. C., III, Warren, D., & Prato, D. (2015) · Open Journal of Medical Microbiology · doi:10.4236/ojmm.2015.53018 · Cited by 8
Candidaemia in a tertiary hospital in Nigeria
Oladele, R. O., Bakare, R. A., Petrou, M. A., Oduyebo, O. O., & Richardson, M. D. (2014) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v3i1.89 · Cited by 9
on behalf of the China-SCAN Team, Cui, N., Wang, H., Su, L., Qiu, H., Li, R., & Liu, D. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2207-1 · Cited by 10
“Invasive candidiasis infection (ICI) is the most common and important part of IFI [3, 4].”
BackgroundInfluentialRecomendaciones para el diagnóstico de la candidemia en América Latina
Colombo, A. L., Cortés, J. A., Zurita, J., Guzmán-Blanco, M., Matute, T. A., Telles, F. D. Q., Santolaya, M. E., Tiraboschi, I. N., Echevarria, J. I., Sifuentes‐Osornio, J., et al. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.05.009 · Cited by 14
Commensal to Pathogen Transition of Candida albicans
Niemiec, M. J., Kapitan, M., Polke, M., & Jacobsen, I. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.12077-1 · Cited by 9
Zand, F., Mohsen, Davarpanah, M. A., Masjedi, M., Nikandish, R., Amanati, A., Afarid, M., Nafarieh, L., & Nami, M. (2016) · Bioscience Biotechnology Research Communications · doi:10.21786/bbrc/9.3/6 · Cited by 7
“Based on the available evidence, IC subjects to high mortality rate ranging between 40 to 60% (Falagas, Apostolou, & Pappas, 2006; Guery et al., 2009; Leroy et al., 2009), and the mortality may reach 100% under certain conditions (Kollef et al.”
BackgroundThe impact of real life treatment strategies forCandidaperitonitis—A retrospective analysis
Dubler, S., Laun, M., Koch, C., Hecker, A., Weiterer, S., Siegler, B. H., Röhrig, R., Weigand, M. A., & Lichtenstern, C. (2017) · Mycoses · doi:10.1111/myc.12615 · Cited by 8
Horn, J., Mullholand, J. B., Ashraf, S., Shore, D., & de Louw, A. V. (2021) · American Journal of Case Reports · doi:10.12659/ajcr.933847 · Cited by 6
“The patient had several risk factors for candidemia (age, mechanical ventilation, central venous catheter, broad-spectrum antibiotics) [36], and whether steroids Horn J.”
BackgroundDeep-seated Candida infections in the intensive care unit
Brusselaers, N., Blot, S. I., & Vogelaers, D. (2011) · Ghent University Academic Bibliography (Ghent University) · Cited by 9
Poth, J. M., Schmandt, M., Schewe, J., Lehmann, F., Kreyer, S., Kohistani, Z., Bakhtiary, F., Hischebeth, G. T. R., Putensen, C., Weller, J. M., et al. (2024) · Journal of Critical Care · doi:10.1016/j.jcrc.2024.154831 · Cited by 5
Self-citationRahbar, M., Vossoghian, S., Alimehr, S., Abad, H. S. E., Mohammadzadeh, M., Fallah, F., Tabatabaei, S. R., Khodadadi, E., & Saremi, M. (2016) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.36166 · Cited by 5
“These outcomes are similar to those reported by others (20-23).”
ResultDecker, S., Incamps, A., Sigl, A., Uhle, F., Bruckner, T. M., Heininger, A., Zimmermann, S., Hirtz, C., Weigand, M. A., & Brenner, T. (2020) · Mediators of Inflammation · doi:10.1155/2020/3470163 · Cited by 5
“are responsible for no more than 5% of all cases with sepsis or septic shock, the occurrence of candidemia is associated with a septic disease course in 10–40% of cases [15].”
BackgroundMolecular detection of Candida species from hospitalized patients’ specimens
Camacho-Cardoso, J. L., Martínez-Rivera, M. Á., Manzano–Gayosso, P., Méndez‐Tovar, L. J., López‐Martínez, R., & Hernández, F. H. (2023) · Gaceta Médica de México · doi:10.24875/gmm.m18000045 · Cited by 5
Commensal to Pathogen Transition of Candida albicans
Jacobsen, I. D., Niemiec, M. J., Kapitan, M., & Polke, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.21281-8 · Cited by 6
Tunay, B., & Aydın, S. (2022) · Science Progress · doi:10.1177/00368504221124055 · Cited by 4
Poth, J. M., Schewe, J., Lehmann, F., Weller, J. M., Schmandt, M., Kreyer, S., Muenster, S., Putensen, C., & Ehrentraut, S. (2023) · Journal of Fungi · doi:10.3390/jof9070751 · Cited by 4
Self-citationKubota, H., Endo, H., Minegishi, S., Tsuchiya, H., Inaba, Y., Takahashi, Y., Shimasaki, T., Kurai, D., Nakazawa, H., & Ohura, N. (2024) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezae378 · Cited by 4
Invasive candidiasis in critically ill patients
Kaaniche, F. M., Allela, R., Cherif, S., & Algia, N. B. (2016) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2016.11.002 · Cited by 7
Kim, D., Hwang, G. Y., Yoo, G., Kim, J., & Uh, Y. (2017) · Annals of Clinical Microbiology · doi:10.5145/acm.2017.20.3.53 · Cited by 5
Detección molecular de especies de Candida en especímenes de pacientes hospitalizados
Camacho-Cardoso, J. L., Martínez-Rivera, M. Á., Manzano–Gayosso, P., Méndez‐Tovar, L. J., López‐Martínez, R., & Hernández, F. H. (2017) · Gaceta Médica de México · doi:10.24875/gmm.17002535 · Cited by 6
Yıldırmak, T., Gedık, H., Şimşek, F., İris, N., & Gücüyener, A. (2014) · West Indian Medical Journal · doi:10.7727/wimj.2012.140 · Cited by 3
“Amphotericin B or ecinocandins should be chosen for patients who have history of azole exposure in case of development of C krusei and C glabrata fungaemias that have higher azole resistance rates, as in our study (42, 43).”
ResultSepsis increases the risk of in-hospital cardiac arrest: a population-based analysis
Liu, Y., Yo, C., Hu, J., Hsu, W., Hsiung, J.-C., Chang, Y.-H., Chen, S., & Lee, C. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03475-6 · Cited by 3
Azzawi, M. A. D. A., Abdat, W., Alhamed, A., Alhothali, A. S. A., Alsheikh, R., Almajed, H. M., Alhamdi, S. I. S., Alshahrani, N. N. A., & Eltayeb, A. O. (2025) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2025.116994 · Cited by 3
Invasive candidiasis following liver transplantation and surgical complications
Auzinger, G. M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02135.x · Cited by 3
Self-citationPfeifer, R. A., Iwen, P. C., Qiu, F., Rupp Mark, E., & Hermsen, E. D. (2011) · Infectious Disease Reports · doi:10.4081/idr.2011.e1 · Cited by 3
Amin, A. M., Mohammad, N. S., & Saeed, C. H. (2014) · Zanco Journal of Medical Sciences · doi:10.15218/zjms.2014.0042 · Cited by 6
Yeast Infections After Solid Organ Transplantation
McCarty, T. P., & Pappas, P. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-28797-3_38 · Cited by 3
Retrospective evaluation of candida infections in pediatric intensive care units
Çoban, Y., Köker, A., Tuncer, G. Ö., Akbaş, Y., Köker, S. A., & Kara, T. T. (2023) · Trends in Pediatrics · doi:10.59213/tp.2023.37450 · Cited by 3
Epidemiología de la candidemia en el Hospital México
Vindas, J. V., Cordero, J. A. C., Montoya, A. A. A., Gil, M. C. P., Somogyi, T., & Sandoval, L. (2020) · Acta Médica Costarricense · doi:10.51481/amc.v58i1.908 · Cited by 4
Laderas, J. C. P. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70012-9 · Cited by 2
Invasive Candidiasis and the Utility of Antifungal Susceptibility Testing in the ICU
Coyle, E. A. (2010) · Journal of Pharmacy Practice · doi:10.1177/0897190009356552 · Cited by 2
“Numerous studies have shown invasive candidiasis to be associated with a crude mortality of 40% to 70% and attributable mortality rates of 20% to 50%.(1,9,11) Although potent antifungals are available for the treatment of invasive candidiasis, difficulties or delays in diagnosis, species variation, and antifungal resi…”
BackgroundGetting it right first time in a patient with Candida peritonitis
de Lange, D. W. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02140.x · Cited by 2
Invasive Candidiasis in the Intensive Care Unit
Krishnan, S., & Ostrosky-Zeichner, L. L. (2010) · Hospital Practice · doi:10.3810/hp.2010.04.298 · Cited by 2
“Although there are a limited number of studies focusing on Candida infections in the ICU alone, it represents one-third of all IC and is associated with a high mortality rate.(5) Approximately 33% to 55% of IC infections occur in patients in the ICU, with mortality rates ranging from 5% to 71%.”
BackgroundResultNosocomial candidemia: a threat beyond nosocomial bacterial infections in intensive care units
MEŞE, E. A., Ağkuş, Ç., COŞKUN, R., Metan, G., Koç, A. N., Sungur, M., & Doğanay, M. (2011) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1007-935 · Cited by 1
“Prior surgery, especially gastrointestinal surgery, is another familiar risk factor for candidemia (1).”
BackgroundInfluentialFungi are Not All “Fun-Guys” after All
Poeta, M. D. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00105 · Cited by 1
“As a result, Candida is the fourth most common hospital acquired sepsis (Perlroth and Choi, 2007; Guery et al., 2009; Rueping et al., 2009), and infection with mold Aspergillus spp. is increasing in patients with hematological malignancies (Munoz et al., 2008; Ruping et al., 2008).”
BackgroundParticularidades clínicas del paciente crítico con infección fúngica invasora
Borges-Sa, M., & Aranda-Pérez, M. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.03.008 · Cited by 3
Jiman-Fatani, A. A., Meawed, T. E., & El-Hossary, D. (2015) · The International Arabic Journal of Antimicrobial Agents · doi:10.3823/770 · Cited by 1
Fungal infections in Intensive Care Service of a specialized hospital Adults
Gill, G. (2016) · Revista del Nacional (Itaguá) · doi:10.18004/rdn2015.0007.02.007-014 · Cited by 2
Interactions of Bacteria and Fungi at the Surface
Dworniczek, E., Franiczek, R., Nawrot, U., & Gościniak, G. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733366-00148 · Cited by 2
Probiotics in Invasive Candidiasis
Colombo, J., & Arena, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00048-4 · Cited by 2
Ferrer, R., Zaragoza, R., Llinares, P., Maseda, E., Rodríguez, A. H., & Quindós, G. (2016) · Medicina Intensiva (English Edition) · doi:10.1016/j.medin.2016.07.003 · Cited by 2
Assessment of Ocular Findings in Patients With Candidemia in Intensive Care Unit
Istanbul Kanuni Sultan Suleyman Egitim ve Arastirma Hastanesi, I. H. V. K. M. K., İnci, A., Ünsel, M., Istanbul Kanuni Sultan Suleyman Egitim ve Arastirma Hastanesi, A. V. R. K., Kaya, E., Istanbul Kanuni Sultan Suleyman Egitim ve Arastirma Hastanesi, A. V. R. K., Salihoğlu, Z., & Istanbul Kanuni Sultan Suleyman Egitim ve Arastirma Hastanesi, A. V. R. K. (2020) · Klimik Dergisi/Klimik Journal · doi:10.5152/kd.2019.81 · Cited by 1
Spezielle nosokomiale Infektionen auf der Intensivstation
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-23135-3.10007-8 · Cited by 1
MALDI-TOF MS: the proteomic approach, the future of fungal identification in India
Fonseca, M., Menon, S., Rahi, P., Patekar, P., & Chowdhary, A. S. (2020) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20202898 · Cited by 1
“Encountered commonly in immune-compromised patients, especially those with HIV/AIDS, diabetes, haematological malignancies and in transplant recipients, these fungal infections not only have a high mortality rate of 35-75% but also cause several underlying surgical and medical morbidities, and these patients are frequ…”
BackgroundInvasive Candidiasis in Surgical Patients
Sganga, G., Fransvea, P., Pepe, G., Grezia, M. D., & Cozza, V. (2021) · Hot topics in acute care surgery and trauma · doi:10.1007/978-3-030-62116-2_20 · Cited by 1
Self-citationFerrer, R., de la Cámara, A. G., Ramos, I. J., Quindós, G., & Tejerina, M. T. (2013) · Actualidad en farmacología y terapéutica · Cited by 5
Lemmen, S. (2014) · Springer eBooks · doi:10.1007/978-3-642-54953-3_71 · Cited by 1
Benders, P. M. B., Schouten, J. A., Vena, A., Buil, J. B., Bronkhorst, E., & Bassetti, M. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10644-9 · Cited by 2
Motta, A. L. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2009.tde-24092009-151713 · Cited by 2
Antibiotika, Prophylaxe und Antimykotika
Lemmen, S. (2008) · Springer eBooks · doi:10.1007/978-3-540-72296-0_62
Mikrobiologie und Antiinfektiva
Grabein, B., & Röhrig, S. (2013) · Springer eBooks · doi:10.1007/978-3-642-34433-6_26
Indications des antifongiques systémiques, spécialité par spécialité
de Guibert, S., Gandemer, V., Belleguic, C., Revest, M., Camus, C., Caulet-Maugendre, S., Cardiet, I., Faucheux, M., Meunier, C. M., & Gangneux, J. (2010) · HAL · doi:10.1684/met.2010.0282
“Par contre une échinocandine (caspofungine 70 mg en dose de charge puis 50 mg/j, micafungine 100 mg/j, anidulafungine 200 mg puis 100/j) doit être préférée pour les patients sévères quelle que soit l’exposition antérieure aux azolés [65, 85].”
BackgroundDNA Microarray-Based Detection and Identification of Fungal Specimens
Mäki, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2356-0_53
Non–Culture-Based Methods for the Diagnosis of Invasive Candidiasis
Mayr, A., & Lass‐Flörl, C. (2011) · Current Fungal Infection Reports · doi:10.1007/s12281-011-0060-z · Cited by 1
Invasive fungal infections: What to do if there's a fungus among us among us
O’Donnell, J. N. (2015)
Fungal Infections in the Elderly
Revelas, A., Liannos, E., & Arvanitakis, D. (2013) · Afro-Egyptian Journal of Infectious and Endemic Diseases · doi:10.21608/aeji.2013.17093
Al-Sofyani, K. A., Uddin, M. S., Alghamdi, H. S., & El-Hossary, D. (2020) · Acta Scientific Paediatrics · doi:10.31080/aspe.2020.03.0318 · Cited by 1
Approaches Towards the Detection of Sepsis: A Review
Heeroma, A. J., Toffrey, J., & Gwenin, C. D. (2021) · International Journal of Biomedical and Clinical Analysis · doi:10.61797/ijbca.v1i1.53
New Developments in Diagnostics and Management of Invasive Candidiasis
Krishnan, S., & Ostrosky-Zeichner, L. L. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch28 · Cited by 1
Paiva, J. A., & Pereira, J. M. (2012) · Springer eBooks · doi:10.1007/978-3-642-00418-6_25
Antibiotika, Prophylaxe und Antimykotika
Lemmen, S. (2011) · Springer eBooks · doi:10.1007/978-3-642-16929-8_62
Iwen, P. C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00061-0 · Cited by 2
Mikrobiologie und Antiinfektiva
Grabein, B., & Röhrig, S. (2011) · Springer eBooks · doi:10.1007/978-3-642-12448-8_24
Fresenius, M. (2014) · Springer eBooks · doi:10.1007/978-3-642-44933-8_15
Mathur, V., & Amar, P. K. (2025) · Indian Journal of ECMO · doi:10.5005/jaypee-journals-11011-0035
Samanta, S., Chaudhury, T., Syed, S., Das, S., Ghosh, A., & Kundu, S. (2026) · Bengal Physician Journal · doi:10.5005/jp-journals-10070-8114
Martín‐Loeches, I., & Yu, Y. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2726965
Mendes, J. (2012) · Revista Portuguesa de Doenças Infecciosas (RPDI) · doi:10.65332/rpdi.v8.215 · Cited by 5
Dyk, J. K. V. (2020) · Nelson Mandela University Research Repository
In vitro Combinatorial Effects of 18β-Glycyrrhetinic Acid with Azole Antifungals
Zeng, Y., Hu, J., Ge, L., Yu, J., Tang, M., Tan, J., Zhang, H., & Sun, Y. (2026) · Infection and Drug Resistance · doi:10.2147/idr.s631019
Sganga, G. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02142.x
Self-citationAntibiotika, Antibiotikaprophylaxe und Antimykotika in der Intensivmedizin
Lemmen, S. (2015) · Springer eBooks · doi:10.1007/978-3-642-54675-4_82-1
Metadata
- Authors
- Guery, B. P., Arendrup, M. C., Auzinger, G., Azoulay, É., Borges Sá, M., Johnson, E. M., Müller, E., Putensen, C., Rotstein, C., Sganga, G., Venditti, M., Zaragoza Crespo, R., & Kullberg, B. J.
- Affiliations
- Statens Serum Institut (DK)
- King's College Hospital (GB)
- Hôpital Saint-Louis (FR)
- University Hospitals of the Ruhr-University of Bochum (DE)
- University of Bonn (DE)
- University Health Network (CA)
- Università Cattolica del Sacro Cuore (IT)
- Sapienza University of Rome (IT)
- Radboud University Nijmegen (NL)
- Corresponding author
- Kullberg, Bart Jan
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2008-10-30
- Volume
- 35
- Issue
- 1
- Pages
- 55-62
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2012383276
- Semantic Scholar
- cd5e9d6d2f04b85eba8f5f641d0d646b8f63bdb4
- Cited by
- 173
- References
- 58
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 4 · 2017: 11 · 2016: 15 · 2015: 17 · 2014: 18 · 2013: 14 · 2012: 11
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Intensive Care Medicine (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Docusalut (Conselleria de Salut i Consum del Govern de les Illes Balears) (submittedVersion, cc-by-nc)
- Hispana (submittedVersion, cc-by-nc)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, other-oa)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Pfizer
- Sanofi
- Gilead Sciences
- Fresenius Medical Care North America
- Astellas Pharma
- Novartis Pharma
- Bayer Vital
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- invasive candidiasis, candidemia, non-neutropenic patients, intensive care unit, Candida albicans, Candida glabrata, nosocomial fungal infections, risk factors, clinical scoring systems, blood culture, β-1,3-glucan, mannan, PCR detection, antifungal therapy, epidemiology
- MeSH terms
- Candidiasis, Cross Infection, Europe, Humans, Intensive Care Units, Turkey, Biomarkers, Prevalence, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.